Skip to main content

Table 1 Baseline characteristics and participant profiles

From: Efficacy of a self-management program in patients with chronic viral hepatitis in China

Variable Intervention group Usual care group p value
(n = 30) (n = 30)
Characteristics n (%) or n (%) or  
mean ± SD mean ± SD  
 Females 15 (50.0) 6 (20.0) 0.029a*
 Employed 25 (83.3) 22 (73.3) 0.532a
 Marital status: married 26 (86.7) 26 (86.7) 1.000a
 Living with another person 28 (93.3) 27 (90.0) 1.000a
 Age (years) 33.2 ± 7.29 36.6 ± 10.56 0.152b
Subject profiles
 Comorbidity 25 (83.3) 22 (73.3) 0.532a
 Diabetes mellitus 27 (90.0) 28 (93.3) 1.000a
 Recurrent history of liver disease in the past 2 years 19 (63.3) 14 (46.7) 0.299a
 Use of insulin 29 (96.7) 28 (93.3) 1.000a
Treatment regimen
 Antiviral medicine 11 (36.7) 9 (30.0) 0.785a
 Anti-fibrosis therapy 13 (43.3) 15 (50.0) 0.796a
 Immunotherapy 4 (13.3) 6 (20.0) 0.731a
 Liver protection therapy 27 (90.0) 28 (93.9) 1.000a
 Peg interferon 11 (36.7) 14 (46.7) 0.601a
Types of hepatitis
 Hepatitis B 26 (86.7) 26 (86.7) 1.000a
 Hepatitis C 4 (13.3) 4 (13.3)
  1. SD Standard Deviation
  2. *p <  0.05
  3. a p value is based on Pearson’s chi-square test
  4. b p value is based on t-test